Predictive Oncology Inc logo

Predictive Oncology Inc

$ 0.37 +0.0464 (+14.34%) 10:08 PM EST
P/E:
At Loss
P/B:
0.97
Market Cap:
$ 29.13M
Enterprise V:
$ 309.00K
Volume:
397.63K
Avg Vol (2M):
306.10K
Also Trade In:
Volume:
397.63K
Market Cap $:
29.13M
PE Ratio:
At Loss
Avg Vol (2-Month):
306.10K
Enterprise Value $:
309.00K
PB Ratio:
0.97
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.
Name Current Vs Industry Vs History
Cash-To-Debt 112.86
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.59
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 94.63
9-Day RSI 85.38
14-Day RSI 75.15
6-1 Month Momentum % -32.21
12-1 Month Momentum % -75.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.74
Quick Ratio 7.6
Cash Ratio 7.32
Days Inventory 331.42
Days Sales Outstanding 70.11
Days Payable 758.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -259.8

Financials (Next Earnings Date:2023-02-10 Est.)

POAI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:POAI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.619
EPS (TTM) ($) -0.38
Beta 0.25
Volatility % 65.55
14-Day RSI 75.15
14-Day ATR ($) 0.028681
20-Day SMA ($) 0.27794
12-1 Month Momentum % -75.93
52-Week Range ($) 0.21 - 1.1
Shares Outstanding (Mil) 78.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Predictive Oncology Inc Filings

Document Form Filing Date
No Filing Data

Predictive Oncology Inc Analysis

Share your research

Headlines

See More
No news.